IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	109.1	157.78	68.74	92.15	72.14	34.17
Short-Term Investments	590.43	368.1	296.2	154.72	211.55	64.89
Cash & Cash Equivalents	699.53	525.87	364.94	246.88	283.69	99.06
Cash Growth	106.00%	44.10%	47.82%	-12.98%	186.38%	9.99%
Receivables	0.02	0.02	0.21	1.1	1.88	0
Other Current Assets	9.81	6.74	5.31	3.02	3.04	2.59
Total Current Assets	709.35	532.63	370.45	251	288.61	101.65
Property, Plant & Equipment	8.69	8.41	8.99	8.66	9.48	9.7
Long-Term Investments	242.64	107.49	8.32	121.29	0	1.53
Other Long-Term Assets	0.85	0.78	0.21	0.4	0.19	0.12
Total Long-Term Assets	252.17	116.68	17.52	130.35	9.66	11.35
Total Assets	961.53	649.32	387.97	381.35	298.27	113
Accounts Payable	6.29	6.6	4.28	2.1	0.95	0.71
Current Debt	1.15	1.75	1.87	1.7	1.54	1.15
Other Current Liabilities	17.52	18.76	25.57	41.36	36.15	5.09
Total Current Liabilities	24.96	27.1	31.72	45.16	38.64	6.94
Long-Term Debt	1.26	1.13	1.61	3.48	5.18	5.63
Other Long-Term Liabilities	0	0	5.19	31.19	56.17	0.03
Total Long-Term Liabilities	1.26	1.13	6.8	34.67	61.36	5.66
Total Liabilities	26.22	28.23	38.51	79.83	100	12.6
Total Debt	2.41	2.87	3.48	5.18	6.72	6.77
Debt Growth	-20.59%	-17.52%	-32.79%	-22.94%	-0.72%	-
Retained Earnings	-387.94	-348.36	-235.4	-176.75	-126.99	-92.49
Comprehensive Income	-0.92	0.56	-2.87	-0.71	0.01	0.07
Shareholders' Equity	935.31	621.09	349.46	301.51	198.27	100.4
Net Cash / Debt	697.12	523	361.45	241.7	276.97	92.29
Net Cash / Debt Growth	107.14%	44.69%	49.55%	-12.74%	200.11%	2.47%
Net Cash Per Share	9.28	9.09	8.72	6.86	11.20	7.38
Working Capital	684.39	505.53	338.74	205.84	249.97	94.71
Book Value Per Share	12.45	10.80	8.43	8.55	8.02	8.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).